DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.02 Billion USD | 40.51% |
| 2022 | 1.44 Billion USD | 87.61% |
| 2021 | 769.2 Million USD | -24.73% |
| 2020 | 1.02 Billion USD | 46.09% |
| 2019 | 699.5 Million USD | 652.09% |
| 2018 | -126.7 Million USD | -11.24% |
| 2017 | -113.9 Million USD | -28.7% |
| 2016 | -88.5 Million USD | -5.61% |
| 2015 | -83.8 Million USD | -24.7% |
| 2014 | -67.2 Million USD | -84.62% |
| 2013 | -36.4 Million USD | -3209.09% |
| 2012 | -1.1 Million USD | 56.91% |
| 2011 | -2.55 Million USD | 41.5% |
| 2010 | -4.36 Million USD | -110.13% |
| 2009 | 43.08 Million USD | -14.96% |
| 2008 | 50.65 Million USD | 28.93% |
| 2007 | 39.29 Million USD | 359.5% |
| 2006 | -15.14 Million USD | 59.35% |
| 2005 | -37.24 Million USD | -36.79% |
| 2004 | -27.22 Million USD | -36.04% |
| 2003 | -20.01 Million USD | 0.0% |
| 2001 | -7.77 Million USD | 44.04% |
| 2000 | -13.89 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 1.81 Billion USD | 19.03% |
| 2024 Q1 | 1.73 Billion USD | -14.24% |
| 2024 Q2 | 1.65 Billion USD | -4.82% |
| 2023 FY | 2.02 Billion USD | 40.51% |
| 2023 Q4 | 2.02 Billion USD | 0.52% |
| 2023 Q2 | 2.11 Billion USD | 39.39% |
| 2023 Q1 | 1.51 Billion USD | 5.3% |
| 2023 Q3 | 2.01 Billion USD | -4.76% |
| 2022 Q1 | 1.42 Billion USD | 85.35% |
| 2022 FY | 1.44 Billion USD | 87.61% |
| 2022 Q2 | 1.4 Billion USD | -1.66% |
| 2022 Q3 | 1.43 Billion USD | 2.28% |
| 2022 Q4 | 1.44 Billion USD | 0.63% |
| 2021 Q1 | 1.13 Billion USD | 11.43% |
| 2021 Q2 | 735.2 Million USD | -35.44% |
| 2021 Q3 | 439.2 Million USD | -40.26% |
| 2021 Q4 | 769.2 Million USD | 75.14% |
| 2021 FY | 769.2 Million USD | -24.73% |
| 2020 Q3 | 1.14 Billion USD | -5.96% |
| 2020 Q1 | 593.8 Million USD | -15.11% |
| 2020 Q2 | 1.21 Billion USD | 105.05% |
| 2020 Q4 | 1.02 Billion USD | -10.75% |
| 2020 FY | 1.02 Billion USD | 46.09% |
| 2019 FY | 699.5 Million USD | 652.09% |
| 2019 Q4 | 699.5 Million USD | -2.18% |
| 2019 Q3 | 715.1 Million USD | 89.78% |
| 2019 Q2 | 376.8 Million USD | 283.18% |
| 2019 Q1 | -205.7 Million USD | -62.35% |
| 2018 Q1 | -89.1 Million USD | 21.77% |
| 2018 Q3 | -21.3 Million USD | -150.59% |
| 2018 Q4 | -126.7 Million USD | -494.84% |
| 2018 FY | -126.7 Million USD | -11.24% |
| 2018 Q2 | 42.1 Million USD | 147.25% |
| 2017 Q2 | -68.7 Million USD | 4.32% |
| 2017 Q4 | -113.9 Million USD | -59.52% |
| 2017 FY | -113.9 Million USD | -28.7% |
| 2017 Q1 | -71.8 Million USD | 18.22% |
| 2017 Q3 | -71.4 Million USD | -3.93% |
| 2016 Q4 | -87.8 Million USD | 4.25% |
| 2016 FY | -88.5 Million USD | -5.61% |
| 2016 Q3 | -91.7 Million USD | -12.52% |
| 2016 Q2 | -81.5 Million USD | -6.96% |
| 2016 Q1 | -76.2 Million USD | 9.07% |
| 2015 Q2 | -64.2 Million USD | -28.14% |
| 2015 Q3 | -82.4 Million USD | -28.35% |
| 2015 Q4 | -83.8 Million USD | -1.7% |
| 2015 FY | -83.8 Million USD | -24.7% |
| 2015 Q1 | -50.1 Million USD | 25.45% |
| 2014 FY | -67.2 Million USD | -84.62% |
| 2014 Q2 | -43.7 Million USD | -10.91% |
| 2014 Q3 | -58 Million USD | -32.72% |
| 2014 Q4 | -67.2 Million USD | -15.86% |
| 2014 Q1 | -39.4 Million USD | -8.24% |
| 2013 Q4 | -36.4 Million USD | -37.88% |
| 2013 Q3 | -26.4 Million USD | -24.53% |
| 2013 FY | -36.4 Million USD | -3209.09% |
| 2013 Q2 | -21.2 Million USD | -78.15% |
| 2013 Q1 | -11.9 Million USD | -981.82% |
| 2012 Q3 | -4.74 Million USD | 20.74% |
| 2012 Q4 | -1.1 Million USD | 76.81% |
| 2012 Q2 | -5.98 Million USD | -16.92% |
| 2012 Q1 | -5.11 Million USD | -100.51% |
| 2012 FY | -1.1 Million USD | 56.91% |
| 2011 Q1 | -3.5 Million USD | 19.68% |
| 2011 Q3 | -17.52 Million USD | 48.18% |
| 2011 Q4 | -2.55 Million USD | 85.43% |
| 2011 FY | -2.55 Million USD | 41.5% |
| 2011 Q2 | -33.81 Million USD | -864.74% |
| 2010 Q4 | -4.36 Million USD | 8.68% |
| 2010 Q1 | -4.83 Million USD | -111.22% |
| 2010 FY | -4.36 Million USD | -110.13% |
| 2010 Q2 | -1.9 Million USD | 60.53% |
| 2010 Q3 | -4.77 Million USD | -150.6% |
| 2009 FY | 43.08 Million USD | -14.96% |
| 2009 Q3 | 39.22 Million USD | -3.64% |
| 2009 Q4 | 43.08 Million USD | 9.84% |
| 2009 Q2 | 40.7 Million USD | 16.23% |
| 2009 Q1 | 35.01 Million USD | -30.87% |
| 2008 Q1 | 41.11 Million USD | 4.63% |
| 2008 FY | 50.65 Million USD | 28.93% |
| 2008 Q2 | 59.53 Million USD | 44.81% |
| 2008 Q4 | 50.65 Million USD | -14.55% |
| 2008 Q3 | 59.28 Million USD | -0.42% |
| 2007 Q2 | 37.21 Million USD | 388.96% |
| 2007 Q4 | 39.29 Million USD | -17.41% |
| 2007 FY | 39.29 Million USD | 359.5% |
| 2007 Q1 | 7.61 Million USD | 150.26% |
| 2007 Q3 | 47.57 Million USD | 27.85% |
| 2006 Q2 | -22.47 Million USD | -11.38% |
| 2006 Q3 | -20.5 Million USD | 8.79% |
| 2006 FY | -15.14 Million USD | 59.35% |
| 2006 Q4 | -15.14 Million USD | 26.15% |
| 2006 Q1 | -20.18 Million USD | 45.82% |
| 2005 Q3 | -42.11 Million USD | 18.2% |
| 2005 Q1 | -4.64 Million USD | 0.0% |
| 2005 Q2 | -51.49 Million USD | -1008.72% |
| 2005 Q4 | -37.24 Million USD | 11.57% |
| 2005 FY | -37.24 Million USD | -36.79% |
| 2004 FY | -27.22 Million USD | -36.04% |
| 2003 FY | -20.01 Million USD | 0.0% |
| 2001 FY | -7.77 Million USD | 44.04% |
| 2000 FY | -13.89 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -7387.261% |
| BrainsWay Ltd. | -10.32 Million USD | 19748.256% |
| Cerus Corporation | 84.35 Million USD | -2303.855% |
| Envoy Medical, Inc. | -3.81 Million USD | 53264.657% |
| electroCore, Inc. | -9.95 Million USD | 20468.659% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 39664.878% |
| IceCure Medical Ltd | -9.93 Million USD | 20511.717% |
| Inogen, Inc. | -103.56 Million USD | 2057.825% |
| OrthoPediatrics Corp. | -9.26 Million USD | 21980.868% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 55790.744% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 15582.127% |
| MaxCyte, Inc. | -27.76 Million USD | 7403.606% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 39564.058% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 352273.709% |
| Orthofix Medical Inc. | 96.44 Million USD | -2002.507% |
| PAVmed Inc | 29.08 Million USD | -6871.395% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 12070.6% |
| RxSight, Inc. | -6.68 Million USD | 30454.79% |
| Sight Sciences, Inc. | -102.71 Million USD | 2074.103% |
| SI-BONE, Inc. | 5.72 Million USD | -35343.104% |
| TELA Bio, Inc. | -3.94 Million USD | 51447.177% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -3437.447% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -575951.136% |
| Acutus Medical, Inc. | 12.27 Million USD | -16413.56% |
| Talis Biomedical Corporation | -57.06 Million USD | 3653.379% |
| Spectral AI, Inc. | -3.5 Million USD | 58017.738% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 4322.0% |
| CVRx, Inc. | -59.95 Million USD | 3481.98% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -102095.152% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -158607.051% |
| Bioventus Inc. | 372.51 Million USD | -444.331% |
| Venus Concept Inc. | 74.3 Million USD | -2629.035% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 20014.555% |
| LivaNova PLC | 62.53 Million USD | -3142.66% |
| 908 Devices Inc. | -115.09 Million USD | 1861.747% |
| Alphatec Holdings, Inc. | 320.7 Million USD | -532.255% |
| Nemaura Medical Inc. | 9.92 Million USD | -20330.194% |
| NeuroPace, Inc. | 54.33 Million USD | -3631.711% |
| LENSAR, Inc. | -18.31 Million USD | 11173.067% |
| Apyx Medical Corporation | -5.15 Million USD | 39465.172% |
| Cutera, Inc. | 288.3 Million USD | -603.33% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -26882.036% |
| BioSig Technologies, Inc. | 262 Thousand USD | -773831.298% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 4726.283% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 22142.613% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | -44.292% |
| Axonics, Inc. | -77.19 Million USD | 2726.759% |
| Outset Medical, Inc. | 67.67 Million USD | -2896.055% |
| IRIDEX Corporation | -4.28 Million USD | 47387.78% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 1239.042% |
| IRadimed Corporation | -47.71 Million USD | 4349.237% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 67109.253% |
| INVO Bioscience, Inc. | 8.45 Million USD | -23893.221% |
| Telesis Bio, Inc. | 32.63 Million USD | -6113.268% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 81138.89% |
| Varex Imaging Corporation | 316.9 Million USD | -539.855% |
| Quipt Home Medical Corp. | 81.73 Million USD | -2380.837% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 72986.413% |
| Pulmonx Corporation | -42.36 Million USD | 4886.827% |
| Dynatronics Corporation | 6.2 Million USD | -32583.579% |
| Modular Medical, Inc. | -8.04 Million USD | 25313.877% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 47288.736% |
| Semler Scientific, Inc. | -57.13 Million USD | 3649.274% |
| InMode Ltd. | -135.39 Million USD | 1597.629% |
| Bruker Corporation | 891.3 Million USD | -127.499% |
| Cytosorbents Corporation | 4.18 Million USD | -48386.196% |
| Align Technology, Inc. | -840.47 Million USD | 341.258% |
| Viveve Medical, Inc. | -13.81 Million USD | 14779.65% |
| ZimVie Inc. | 450.41 Million USD | -350.181% |
| Movano Inc. | -5.86 Million USD | 34666.996% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 1608.077% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 352273.709% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -102095.152% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | -468.303% |
| Profound Medical Corp. | -18.17 Million USD | 11254.376% |
| Insulet Corporation | 798.1 Million USD | -154.066% |
| enVVeno Medical Corporation | -2.21 Million USD | 91520.198% |
| Surmodics, Inc. | -12.01 Million USD | 16977.809% |
| iCAD, Inc. | -21.2 Million USD | 9660.564% |
| Nuwellis, Inc. | -2.81 Million USD | 72029.762% |
| Biotricity, Inc. | 23.09 Million USD | -8680.686% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -2065.166% |
| Aethlon Medical, Inc. | -4.5 Million USD | 45143.364% |
| InspireMD, Inc. | -8.04 Million USD | 25304.475% |
| PAVmed Inc. | 29.08 Million USD | -6871.395% |
| BIOLASE, Inc. | 11.34 Million USD | -17774.647% |
| Beyond Air, Inc. | 6.22 Million USD | -32452.577% |
| FONAR Corporation | -14.66 Million USD | 13926.493% |
| AxoGen, Inc. | 32.26 Million USD | -6184.324% |
| Vivani Medical, Inc. | 42 Thousand USD | -4827757.143% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 19125.145% |
| Inari Medical, Inc. | -7.16 Million USD | 28415.874% |
| UFP Technologies, Inc. | 40.77 Million USD | -4873.022% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -65978.477% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 42597.763% |
| Tenon Medical, Inc. | -1.25 Million USD | 161669.721% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 26759.216% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 17101.904% |
| AdaptHealth Corp. | 2.21 Billion USD | 8.56% |
| Sintx Technologies, Inc. | 905 Thousand USD | -223955.249% |
| NanoVibronix, Inc. | -3.27 Million USD | 61957.84% |
| Quanterix Corporation | -132.95 Million USD | 1625.068% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 72986.413% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 9166.398% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | -169.026% |
| TransMedics Group, Inc. | 121.13 Million USD | -1573.931% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 7845.225% |
| NeuroMetrix, Inc. | -1.49 Million USD | 136089.591% |
| Hyperfine, Inc. | -75.61 Million USD | 2781.469% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -1232.356% |
| Biomerica, Inc. | -3.38 Million USD | 60002.511% |
| Bone Biologics Corporation | -3.02 Million USD | 67096.655% |
| AVITA Medical, Inc. | -26.23 Million USD | 7829.985% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 110396.337% |
| Silk Road Medical, Inc | 64.42 Million USD | -3047.478% |